Effects of BM-573, a novel thromboxane A2 inhibitor, on pulmonary hemodynamics in endotoxic shock

B Lambermont, A Ghuysen, J-M Dogné, P Kolh, V Tchana-Sato, P Morimont, P Benoit, P Gérard, B Masereel, V D'Orio

Research output: Contribution to journalArticlepeer-review

Abstract

Thromboxane A2 is considered to be partially responsible for the increase in pulmonary vascular resistance observed after endotoxin administration and to participate in proinflammatory reactions. The effects of a novel dual TXA2 synthase inhibitor and TXA2 receptor antagonist (BM-573) on pulmonary hemodynamics were investigated in endotoxic shock. 30 mins before the start of a 0.5 mg/kg endotoxin infusion, 6 pigs (Endo group) received a placebo infusion and 6 other pigs (Anta group) received a BM-573 infusion. In Endo group, pulmonary artery pressure increased from 25 +/- 1.8 (T0) to 42 +/- 2.3 mmHg (T60) (p
Original languageEnglish
Pages (from-to)224-31
Number of pages8
JournalArchives of Physiology and Biochemistry
Volume111
Issue number3
DOIs
Publication statusPublished - Jul 2003

Keywords

  • Animals
  • Arachidonic Acid
  • Blood Pressure
  • Cardiac Output
  • Female
  • Heart Rate
  • Male
  • Oxygen Consumption
  • Partial Pressure
  • Platelet Aggregation
  • Pulmonary Artery
  • Pulmonary Circulation
  • Shock, Septic
  • Sulfonylurea Compounds
  • Swine
  • Thromboxane A2

Fingerprint

Dive into the research topics of 'Effects of BM-573, a novel thromboxane A2 inhibitor, on pulmonary hemodynamics in endotoxic shock'. Together they form a unique fingerprint.

Cite this